NCT07081581View on ClinicalTrials.gov

Analgesic Effect of Serratus Plane Block With Adjuvant Agents in Breast Cancer Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

February 1, 2023

Study Completion Date

March 1, 2023

Conditions
Breast CancerPost Operative Pain
Interventions
DRUG

Bupivacain

In Group B( control group), bupivacaine was given as additional medication in the serratus block application.

DRUG

Bupivacaine and Magnesium sulfate

In Group M, bupivacaine and magnesium were given as additional medication in the serratus block application.

DRUG

Bupivacaine and Dexmedetomidine ile Blokaj

In Group D, bupivacaine and dexmedetomidine were given as additional medication in the serratus block application.

Trial Locations (1)

34674

Sultan 2. Abdulhamid Han Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

OTHER